Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation

Minoru Tanabe, Motohide Shimazu, Go Wakabayashi, Ken Hoshino, Shigeyuki Kawachi, Tomohisa Kadomura, Hiroaki Seki, Yasuhide Morikawa, Masaki Kitajima

研究成果: Article

126 引用 (Scopus)

抜粋

Background. ABO-incompatible liver transplantation is associated with an extremely complicated postoperative course, especially when the recipients are adults. Methods. Two adult patients underwent living-donor liver transplantation from ABO-incompatible donors. The antirejection therapy included multiple perioperative plasmapheresis, splenectomy, systemic triple immunosuppressive regimen with tacrolimus, methylprednisolone, and cyclophophamide, or azathioprine. In addition to these conventional approaches, we performed intraportal infusion therapy after transplantation with methylprednisolone, prostaglandin E1, and gabexate mesilate. Results. With our protocol, antidonor blood group antibody titers in both cases remained low without any evidence of rejection or vascular complications throughout the postoperative course. Biliary complications were transient and resolved completely. The patients have now survived 30 and 12 months posttransplantation and have regained normal life activity with good liver function. Conclusions. Our experience has shown the feasibility of controlling rejection and other complications in adult ABO-incompatible liver transplantation under intraportal infusion therapy.

元の言語English
ページ(範囲)1959-1961
ページ数3
ジャーナルTransplantation
73
発行部数12
DOI
出版物ステータスPublished - 2002 6 27

    フィンガープリント

ASJC Scopus subject areas

  • Transplantation

これを引用

Tanabe, M., Shimazu, M., Wakabayashi, G., Hoshino, K., Kawachi, S., Kadomura, T., Seki, H., Morikawa, Y., & Kitajima, M. (2002). Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation, 73(12), 1959-1961. https://doi.org/10.1097/00007890-200206270-00021